Intermediate 1-(2-nitro-1-imidazolyl)-3-substituted amino-2-prop

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D23395

Patent

active

047571489

ABSTRACT:
A compound of formula I ##STR1## in which formula: R.sub.1 represents hydrogen or an alkyl group;

REFERENCES:
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal
Stratford, Int. J. Radiation Biol. Phys., vol. 8, 391-392 (1982).
Smith et al., Chemical Abstracts, vol. 95 (1981) No. 17999S.
Cancer-vol. 48, No. 3, Aug. 1, 1981--American Cancer Society Inc., J. P. Lippincott Company--696-707.
Hypoxia Mediated Radiation and Chemo--Sensitizing Drugs Br. J. Cancer (1984), 50, 285-289.
Radiation Sensitization and Chemopotentiation: RSU 1069, a Compound More Efficient than Misonidazole-Br. J. Cancer (1984) 49, 571-577.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Intermediate 1-(2-nitro-1-imidazolyl)-3-substituted amino-2-prop does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediate 1-(2-nitro-1-imidazolyl)-3-substituted amino-2-prop, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediate 1-(2-nitro-1-imidazolyl)-3-substituted amino-2-prop will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-665216

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.